| Literature DB >> 25031861 |
Reza Boostani1, Ali Mellat2, Reza Afshari3, Siavash Derakhshan4, Morteza Saeedi1, Ehsan Rafeemanesh5, Maryam Mellat6.
Abstract
BACKGROUND: The use of organophosphates (OPs) in developing countries is rising in large quantities and non-secure methods. This problem not only causes acute poisoning but also may lead to chronic diseases such as polyneuropathy. In Iran, 60% of pesticides are organophosphate compounds that may lead to delayed polyneuropathy.Entities:
Keywords: Electrodiagnosis; Neurotoxicity Syndromes; Organophosphates; Pesticides; Polyneuropathies
Year: 2014 PMID: 25031861 PMCID: PMC4082521 DOI: 10.5812/ircmj.5072
Source DB: PubMed Journal: Iran Red Crescent Med J ISSN: 2074-1804 Impact factor: 0.611
Age Distribution in Cases and Controls [a]
| Groups | Age, y | P value |
|---|---|---|
|
| 43.4±6.5a | 0.002 |
|
| 40.7±6.0 | |
|
| 44.6±6.3 | 0.153 |
|
| 42.7±6.6 |
a Data are presented as Mean±SD.
Prevalence of Complications in 100 Farm Sprayers
| Complications | Frequency, % |
|---|---|
|
| |
| Sensory symptoms | 37 (37) |
| Sensory signs | 16 (16) |
| Motor symptoms | 2 (2) |
| Motor signs | 0 (0) |
|
| |
| Ophthalmologic | 44 (44) |
| Dermatologic | 40 (40) |
| Pulmonary | 32 (32) |
a Some overlaps exist between complications.
Comparison of Electrodiagnostic Indices Between Cases and Controls, and Frequency of Abnormal Subjects [a]
| Index | Mean ± SD | Number of Abnormal Subjects | ||||
|---|---|---|---|---|---|---|
| Cases | Controls | P value | Cases | Controls | P value | |
|
| ||||||
| CMAP amplitude, mv | 5.4 ± 2.5 | 6.4 ± 1.9 | 0.013 | 5 | 3 | 0.721 |
| CMAP distal latency, ms | 4.8 ± 1.1 | 5 ± 0.9 | 0.435 | 4 | 2 | 0.683 |
| NCV, m/s | 46.8 ± 5.6 | 52.9 ± 5.5 | < 0.001 | 24 | 2 | < 0.001 |
|
| ||||||
| SNAP amplitude, mv | 12.5 ± 4.8 | 13.7 ± 4.7 | 0.090 | 6 | 0 | 0.029 |
| SNAP peak latency, ms | 3.5 ± 0.5 | 3.3 ± 0.5 | 0.006 | 0 | 0 | > 0.999 |
| NCV, m/s | 55.8 ± 10.0 | 56.5 ± 10.1 | 0.669 | 0 | 0 | > 0.999 |
|
| ||||||
| SNAP amplitude, mv | 17.9 ± 7.4 | 21.9 ± 7.8 | < 0.001 | 0 | 0 | > 0.999 |
| SNAP peak latency, ms | 2.6 ± 0.4 | 2.4 ± 0.4 | < 0.001 | 15 | 1 | < 0.001 |
| NCV, m/s | 58.7 ± 8.7 | 61.1 ± 8.1 | 0.046 | 14 | 1 | < 0.001 |
a Abbreviations: CMAP, compound muscle action potential; NCV, nerve conduction velocity; SNAP, sensory nerve action potential.
Duration of Organophosphates Exposure (years) in Farm sprayers [a]
| Cases With Neurologic Complications (n = 40) | Cases Without Neurologic Complications (n = 60) | P value |
|---|---|---|
| 15.7 ± 9.1 | 11.9 ± 6.5 | 0.036 |
a Data are presented as Mean±SD.
Electrodiagnostic Indices and Frequency of Abnormal Subjects in Farms Prayers With (N+) (n = 40) and Without (N‑) (n = 60) Neurologic Complications
| Index | Mean ± SD | Abnormal Subject | ||||
|---|---|---|---|---|---|---|
| N+ | N– | P Value | N+ | N– | P Value | |
|
| ||||||
| CMAP amplitude, mv | 4.2 ± 1.5 | 4.8 ± 2.2 | 0.105 | 1 (2.5) | 4 (6.7) | 0.640 |
| CMAP distal latency, ms | 5.2 ± 0.6 | 4.6 ± 1.3 | 0.008 | 1 (2.5) | 3 (5) | 0.916 |
| NCV, m/s | 45.2 ± 3.1 | 47.9 ± 6.6 | 0.006 | 7 (17.5) | 17 (28.3) | 0.316 |
|
| ||||||
| SNAP amplitude, mv | 12.1 ± 4.2 | 12.8 ± 5.1 | 0.507 | 3 (7.5) | 3 (5) | 0.933 |
| SNAP peak latency, ms | 3.6 ± 0.4 | 3.1 ± 0.5 | < 0.001 | 0 (0) | 0 (0) | > 0.999 |
| NCV, m/s | 50.2 ± 5.2 | 59.9 ± 10.7 | < 0.001 | 0 (0) | 0 (0) | > 0.999 |
|
| ||||||
| SNAP amplitude, mv | 14.9 ± 4.7 | 19.8 ± 8.2 | < 0.001 | 19 (47.5) | 16 (26.7) | 0.054 |
| SNAP peak latency, ms | 2.8 ± 0.4 | 2.5 ± 0.3 | < 0.001 | 13 (27.5) | 2 (3.3) | < 0.001 |
| NCV, m/s | 55.2 ± 6.7 | 61.1 ± 9.1 | < 0.001 | 9 (22.5) | 5 (8.3) | 0.088 |
a Abbreviations: CMAP, compound muscle action potential; NCV, nerve conduction velocity; SNAP, sensory nerve action potential.
b Data are presented as Mean±SD or No. (%).